152 related articles for article (PubMed ID: 37896180)
41. Improved Melatonin Delivery by a Size-Controlled Polydopamine Nanoformulation Attenuates Preclinical Diabetic Retinopathy.
Sardoiwala MN; Nagpal S; Bhatt B; Roy Choudhury S; Karmakar S
Mol Pharm; 2023 Jun; 20(6):2899-2910. PubMed ID: 37116080
[TBL] [Abstract][Full Text] [Related]
42. Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats.
Paterniti I; Di Paola R; Campolo M; Siracusa R; Cordaro M; Bruschetta G; Tremolada G; Maestroni A; Bandello F; Esposito E; Zerbini G; Cuzzocrea S
Eur J Pharmacol; 2015 Dec; 769():313-23. PubMed ID: 26607470
[TBL] [Abstract][Full Text] [Related]
43. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
44. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway.
Sun KX; Chen YY; Li Z; Zheng SJ; Wan WJ; Ji Y; Hu K
World J Diabetes; 2023 Sep; 14(9):1349-1368. PubMed ID: 37771331
[TBL] [Abstract][Full Text] [Related]
45. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
[TBL] [Abstract][Full Text] [Related]
46. Retinal heparanase expression in streptozotocin-induced diabetic rats.
Ma P; Luo Y; Zhu X; Li T; Hu J; Tang S
Can J Ophthalmol; 2010 Feb; 45(1):46-51. PubMed ID: 20130710
[TBL] [Abstract][Full Text] [Related]
47. Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin-induced diabetic rats.
Lei X; He J; Ren C; Zhou Y; Chen X; Dou J
Biomed Pharmacother; 2018 Feb; 98():643-650. PubMed ID: 29289839
[TBL] [Abstract][Full Text] [Related]
48. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
49. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
50. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
51. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
52. Tocotrienol-rich fraction reduces retinal inflammation and angiogenesis in rats with streptozotocin-induced diabetes.
Sadikan MZ; Abdul Nasir NA; Bakar NS; Iezhitsa I; Agarwal R
BMC Complement Med Ther; 2023 Jun; 23(1):179. PubMed ID: 37268913
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4.
Zheng Y; Liu Y; Wang L; Xu H; Lu Z; Xuan Y; Meng W; Ye L; Fang D; Zhou Y; Ke K; Liu Y; An M
Int J Mol Med; 2021 Jan; 47(1):151-160. PubMed ID: 33416109
[TBL] [Abstract][Full Text] [Related]
54. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats.
Wang CF; Yuan JR; Qin D; Gu JF; Zhao BJ; Zhang L; Zhao D; Chen J; Hou XF; Yang N; Bu WQ; Wang J; Li C; Tian G; Dong ZB; Feng L; Jia XB
J Ethnopharmacol; 2016 Jun; 185():162-70. PubMed ID: 26988565
[TBL] [Abstract][Full Text] [Related]
55. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats.
Jian W; Yu S; Tang M; Duan H; Huang J
J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279
[TBL] [Abstract][Full Text] [Related]
56. Dickkopf-1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy.
Xu X; Lan X; Fu S; Zhang Q; Gui F; Jin Q; Xie L; Xiong Y
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 2):69-76. PubMed ID: 35691117
[TBL] [Abstract][Full Text] [Related]
57. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
58. Bergenin alleviates Diabetic Retinopathy in STZ-induced rats.
Yin Y; Xu R; Ning L; Yu Z
Appl Biochem Biotechnol; 2023 Sep; 195(9):5299-5311. PubMed ID: 35622274
[TBL] [Abstract][Full Text] [Related]
59. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
60. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
